SCHEMBL25676523

SCHEMBL25676523

COc1cc(C[n+]2cc[nH]c2C)cc(OC)c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.38
▸ FGFR1 P11362 1/20 0.37
▸ KDR P35968 1/20 0.37
▸ CA1 P00915 1/20 0.36
▸ CA2 P00918 1/20 0.36
▸ CYP19A1 P11511 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ ACHE P22303 2/20 0.34
▸ CALM1 P0DP23 2/20 0.33
▸ AKR1B1 P15121 1/20 0.33
▸ DAO P14920 1/20 0.33
▸ TSHR P16473 2/20 0.33
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ CYP1A2 P05177 1/20 0.32
▸ CYP2E1 P05181 1/20 0.32
▸ CYP3A4 P08684 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14237545 0.86 TAAR1 (0.44) CA1CA2NPC1RAB9AACHE
Water SCHEMBL18281526 0.79 — —
SCHEMBL21698034 0.72 CA1 (0.57) ALDH1A1CA1CA2CYP19A1NPC1
Iodide SCHEMBL5543786 0.71 EEF2K (0.40) ALDH1A1CA1CA2NPC1RAB9A
Hydrochloric Acid SCHEMBL9696543 0.71 KDM4E (0.43) ALDH1A1CA1CA2NPC1RAB9A
SCHEMBL21698036 0.70 CA1 (0.49) ALDH1A1CA1CA2CYP19A1NPC1
SCHEMBL25676541 0.69 SLC6A2 (0.36) ALDH1A1KDM4EMEN1KMT2A
SCHEMBL21698061 0.67 CA1 (0.46) ALDH1A1CA1CA2CYP19A1NPC1
SCHEMBL367258 0.67 ACHE (0.44) ALDH1A1CA1CA2CYP19A1ACHE
Iodide SCHEMBL11405368 0.67 ACHE (0.40) ALDH1A1CA1CA2NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230202986-A1 SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF XIAMEN VIVOHEALTHS TECHNOLOGY CO., LTD. (CN) 2023-06-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230202986-A1 SUBSTITUTED IMIDAZOLE SALT COMPOUNDS, PREPARATION METHOD THEREOF, PHARMACEUTICAL COMPOSITION THEREOF AND APPLICATION THEREOF ALDOA, IDE, ACAT1 ALDH1A1 137/4885FGFR1 2156/4885KDR 3933/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback